Deferoxamine mesylate (Gland Pharma Limited)


Welcome to the PulseAid listing for the Deferoxamine mesylate drug offered from Gland Pharma Limited. This Iron Chelating Activity [MoA],Iron Chelator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Gland Pharma Limited
NON-PROPRIETARY NAME: Deferoxamine mesylate
SUBSTANCE NAME: DEFEROXAMINE MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Iron Chelating Activity [MoA],Iron Chelator [EPC]
ROUTE: INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-10-09
END MARKETING DATE: 0000-00-00


Deferoxamine mesylate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDeferoxamine mesylate from Gland Pharma Limited
LABELER NAME: Gland Pharma Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/1)
START MARKETING DATE: 2017-10-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68083-172_2d0db797-db19-4c14-ba7e-0fcfff1affe5
PRODUCT NDC: 68083-172
APPLICATION NUMBER: ANDA207384

Other DEFEROXAMINE MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Fresenius Kabi USA, LLCDeferoxamine
Gland Pharma LimitedDeferoxamine mesylate
Hospira, Inc.Deferoxamine Mesylate
Novartis Pharmaceuticals CorporationDesferal